Carolyn Jane Blakely v. Elutia, Inc. F/K/A Aziyo Biologics, Inc., et al.

CourtDistrict Court, S.D. California
DecidedJanuary 9, 2026
Docket3:25-cv-02330
StatusUnknown

This text of Carolyn Jane Blakely v. Elutia, Inc. F/K/A Aziyo Biologics, Inc., et al. (Carolyn Jane Blakely v. Elutia, Inc. F/K/A Aziyo Biologics, Inc., et al.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Carolyn Jane Blakely v. Elutia, Inc. F/K/A Aziyo Biologics, Inc., et al., (S.D. Cal. 2026).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 CAROLYN JANE BLAKELY, Case No.: 3:25-cv-02330-CAB-DEB 12 Plaintiff, 13 ORDER DENYING REMAND v. 14 ELUTIA, INC. F/K/A AZIYO 15 BIOLOGICS, INC., et al., [Doc. No. 8] 16 Defendants. 17 18 19 Before the Court is Plaintiff Carolyn Jane Blakely’s motion to remand the action to 20 state court. [Doc. No. 8.] The motion has been fully briefed, and the Court finds it suitable 21 for determination on the papers. See CivLR 7.1(d)(1). For the reasons set forth below, 22 the motion to remand is DENIED. 23 I. BACKGROUND 24 This claim arises out of a spinal surgery performed on Plaintiff in La Jolla, 25 California on April 13, 2023. [Doc. No. 1-2 (“Compl.”) at ¶ 14.] Plaintiff alleges that 26 during this spinal surgery, Plaintiff was implanted with the ViBone product (the “Recalled 27 Product”) and subsequently tested positive for tuberculosis. [Id. at ¶ 14.] The Recalled 28 1 Product is a human tissue allograft consisting of cryopreserved bone matrix that is 2 aseptically processed to preserve native factors that support bone repair. [Id. at ¶ 18.] 3 Plaintiff has named three defendants in connection with making the Recalled Product. 4 Defendant Elutia, Inc. (“Elutia”) formerly did business under the name Aziyo Biologics, 5 Inc. (“Aziyo”). [Id. at ¶ 3.] Plaintiff alleges that Aziyo developed and supplied the 6 Recalled Product. [Id. at ¶¶ 5, 20.] As alleged, Defendant DCI Donor Services, Inc. 7 (“DCI”) harvested and/or supplied the human tissue used in the Recalled Product. [Id. at 8 ¶ 8.] Defendant Berkeley Biologics, LLC (“Berkeley”) purchased Aziyo’s (now Elutia’s) 9 orthobiologics business in 2023 and became Aziyo’s direct successor. [Id. at ¶ 9.] 10 On June 30, 2025, Plaintiff filed a complaint in the Superior Court of the State of 11 California for the County of San Diego asserting claims for: (1) negligence against Elutia 12 and Berkeley; (2) negligence against DCI; (3) strict products liability against Elutia and 13 Berkeley; and (4) breach of implied warranty of merchantability against Elutia and 14 Berkeley. [See generally Compl.] 15 On September 5, 2025, Elutia removed this action to this Court based on diversity 16 jurisdiction. [Doc. No. 1 (“NOR”) at ¶ 6.] On October 2, 2025, Plaintiff filed a motion 17 to remand, contesting that the parties do not have diverse citizenship because Berkeley is 18 a citizen of California. [See Doc. No 8; Doc. No. 8-1 at 1–2.] 19 II. LEGAL STANDARD 20 “A defendant may remove an action to federal court based on federal question 21 jurisdiction or diversity jurisdiction.” Hunter v. Philip Morris USA, 582 F.3d 1039, 1042 22 (9th Cir. 2009) (citing 28 U.S.C. § 1441). Thus, a case brought in state court that originally 23 could have been brought in federal court based on diversity of citizenship is removable. 24 See Caterpillar Inc. v. Williams, 482 U.S. 386, 392 (1987); 28 U.S.C. § 1441(a). 25 “Removal on the basis of diversity jurisdiction requires that the parties be completely 26 diverse and that the amount in controversy exceed $75,000.” Magnum Prop. Invs., LLC 27 v. Pfeiffer, No. 18-CV-02855, 2019 WL 459194, at *2 (S.D. Cal. Feb. 6, 2019); 28 U.S.C. 28 § 1332(a)(1). Defendants have the burden of demonstrating all the requirements for 1 diversity jurisdiction. Hertz Corp. v. Friend, 559 U.S. 77, 96 (2010) (“The burden of 2 persuasion for establishing diversity jurisdiction, of course, remains on the party asserting 3 it.”). 4 For diversity purposes, a natural person is a “citizen” of the state in which he or she 5 is domiciled. Kanter v. Warner–Lambert Co., 265 F.3d 853, 857 (9th Cir. 2001). A 6 corporation is “deemed to be a citizen of every state . . . by which it has been incorporated 7 and of the State . . . where it has its principal place of business.” 28 U.S.C. § 1332(c)(1). 8 For diversity purposes, an LLC is a citizen of every state of which its owners/members 9 are citizens. Johnson v. Columbia Props. Anchorage, LP, 437 F.3d 894, 899 (9th Cir. 10 2006). 11 III. DISCUSSION 12 In the NOR, Defendant argues that this Court has subject matter jurisdiction because 13 complete diversity of citizenship exists and the amount in controversy exceeds $75,000. 14 [NOR at ¶¶ 13, 21.] Plaintiff responds that remand is appropriate because both she and 15 Berkeley are citizens of California, which destroys complete diversity in an otherwise non- 16 removable state-based action. [Doc. No. 8-1 at 1–2.] 17 A. Amount in Controversy 18 To establish federal diversity jurisdiction, the amount in controversy must exceed 19 $75,000. 28 U.S.C. § 1332(a). Plaintiff seeks far more than this amount, [Doc. No. 1-3 20 at 2 (Plaintiff’s Statement of Damages; NOR ¶ 25], and does not dispute that the amount 21 in controversy requirement has been satisfied. The Court finds that Elutia has successfully 22 established the amount in controversy requirement required for diversity jurisdiction. 23 B. Diversity of Citizenship 24 Plaintiff argues that because Plaintiff and Berkeley are both citizens of California, 25 complete diversity is destroyed. [Doc. No. 8-1 at 1–2.] Defendants argue that the Court 26 should find diverse citizenship for two reasons: (1) Berkeley is not a citizen of California, 27 [Doc. No. 14 at 4–6], and (2) even if Berkeley had a member that was a citizen of 28 1 California, this citizenship should be disregarded because Plaintiff fraudulently joined 2 Berkeley to defeat diversity jurisdiction. [Id. at 10–11.] 3 i. Berkeley’s Citizenship 4 Defendants argue that Berkeley is not a California citizen because Berkeley is a 5 wholly owned subsidiary of GNI Group Ltd., which is a Japanese corporation with its 6 principal place of business in Tokyo, Japan. [NOR ¶ 19.] Plaintiff alleges that Berkeley 7 is a Delaware limited liability company with its principal place of business in Richmond, 8 California. [Compl. ¶ 9.] In an attempt to prove Berkeley’s California citizenship, 9 Plaintiff attaches Berkeley’s Statement of Information retrieved from California’s 10 Secretary of State website, which lists two Berkeley “Manager(s) or Member(s)” as each 11 having a California address.1 [Doc. No. 8-3 at 1.] 12 As an LLC, Berkeley is a citizen of every state of which its owners/members are 13 citizens. See Johnson, LP, 437 F.3d at 899. Defendants assert that Berkeley is “a wholly 14 owned subsidiary of GNI Group, Ltd., which is a Japanese corporation with its principal 15 place of business in Tokyo, Japan.” [E.g., Doc. No. 1 at ¶ 9; Doc. No. 14 at ¶ 5]. Plaintiff’s 16 Exhibit 2 to her Motion to Remand lists Berkeley’s ownership as a wholly owned 17 subsidiary of GNI Group Ltd. [Doc. No. 8-4 at 1.] 18 A corporation, whether incorporated in a state of the United States or in a foreign 19 country, is “deemed a citizen of its place of incorporation and the location of its principal 20 place of business.” Nike, Inc. v. Comercial Iberica de Exclusivas Deportivas, S.A., 20 21 F.3d 987, 990 (9th Cir. 1994).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Carolyn Jane Blakely v. Elutia, Inc. F/K/A Aziyo Biologics, Inc., et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/carolyn-jane-blakely-v-elutia-inc-fka-aziyo-biologics-inc-et-al-casd-2026.